Stephanie B Dixon1, Nan Li2, Yutaka Yasui2, Smita Bhatia3, Jacqueline N Casillas4, Todd M Gibson2, Kirsten K Ness2, Jerlym S Porter5, Rebecca M Howell6, Wendy M Leisenring7, Leslie L Robison1, Melissa M Hudson1,2, Kevin R Krull2,5, Gregory T Armstrong2. 1. Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee. 2. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee. 3. Institute for Cancer Outcomes and Survivorship, University of Alabama, Birmingham, Alabama. 4. Department of Pediatrics, Division of Hematology/Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California. 5. Department of Psychology, St. Jude Children's Research Hospital, Memphis, Tennessee. 6. Radiation Physics Department, The University of Texas at MD Anderson Cancer Center, Houston, Texas. 7. Cancer Prevention and Clinical Statistics Programs, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Abstract
BACKGROUND: Survivors of childhood cancer are at risk of neurocognitive impairment, emotional distress, and poor health-related quality of life (HRQOL); however, the effect of race/ethnicity is understudied. The objective of this study was to identify race/ethnicity-based disparities in neurocognitive, emotional, and HRQOL outcomes among survivors of childhood cancer. METHODS: Self-reported measures of neurocognitive function, emotional distress (the Brief Symptom Inventory-18), and HRQOL (the Medical Outcomes Study Short Form-36 health survey) were compared between minority (Hispanic, n = 821; non-Hispanic black [NHB], n = 600) and non-Hispanic white (NHW) (n = 12,287) survivors from the Childhood Cancer Survivor Study (median age, 30.9 years; range, 16.0-54.1 years). By using a sample of 3055 siblings, the magnitude of same-race/same-ethnicity survivor-sibling differences was compared between racial/ethnic groups, adjusting for demographic and treatment characteristics and current socioeconomic status (SES). RESULTS: No clear pattern of disparity in neurocognitive outcomes by race/ethnicity was observed. The magnitude of the survivor-sibling difference in the mean score for depression was greater in Hispanics than in NHWs (3.59 vs 1.09; P = .004). NHBs and Hispanics had greater survivor-sibling differences in HRQOL than NHWs for mental health (NHBs: -5.78 vs -0.69; P = .001; Hispanics: -3.87 vs -0.69; P = .03), and social function (NHBs: -7.11 vs -1.47; P < .001; Hispanics: -5.33 vs -1.47; P = .001). NHBs had greater survivor-sibling differences in physical subscale scores for HRQOL than NHWs. In general, the findings were not attenuated by current SES. CONCLUSIONS: Although no pattern of disparity in neurocognitive outcomes was observed, differences across many HRQOL outcomes among minorities compared with NHWs, not attenuated by current SES, were identified. This suggests that further research into environmental and sociocultural factors during and immediately after treatment is needed.
BACKGROUND: Survivors of childhood cancer are at risk of neurocognitive impairment, emotional distress, and poor health-related quality of life (HRQOL); however, the effect of race/ethnicity is understudied. The objective of this study was to identify race/ethnicity-based disparities in neurocognitive, emotional, and HRQOL outcomes among survivors of childhood cancer. METHODS: Self-reported measures of neurocognitive function, emotional distress (the Brief Symptom Inventory-18), and HRQOL (the Medical Outcomes Study Short Form-36 health survey) were compared between minority (Hispanic, n = 821; non-Hispanic black [NHB], n = 600) and non-Hispanic white (NHW) (n = 12,287) survivors from the Childhood Cancer Survivor Study (median age, 30.9 years; range, 16.0-54.1 years). By using a sample of 3055 siblings, the magnitude of same-race/same-ethnicity survivor-sibling differences was compared between racial/ethnic groups, adjusting for demographic and treatment characteristics and current socioeconomic status (SES). RESULTS: No clear pattern of disparity in neurocognitive outcomes by race/ethnicity was observed. The magnitude of the survivor-sibling difference in the mean score for depression was greater in Hispanics than in NHWs (3.59 vs 1.09; P = .004). NHBs and Hispanics had greater survivor-sibling differences in HRQOL than NHWs for mental health (NHBs: -5.78 vs -0.69; P = .001; Hispanics: -3.87 vs -0.69; P = .03), and social function (NHBs: -7.11 vs -1.47; P < .001; Hispanics: -5.33 vs -1.47; P = .001). NHBs had greater survivor-sibling differences in physical subscale scores for HRQOL than NHWs. In general, the findings were not attenuated by current SES. CONCLUSIONS: Although no pattern of disparity in neurocognitive outcomes was observed, differences across many HRQOL outcomes among minorities compared with NHWs, not attenuated by current SES, were identified. This suggests that further research into environmental and sociocultural factors during and immediately after treatment is needed.
Authors: Raoul C Reulen; David L Winter; Emma R Lancashire; Maurice P Zeegers; Meriel E Jenney; Stephen J Walters; Crispin Jenkinson; Mike M Hawkins Journal: Int J Cancer Date: 2007-08-01 Impact factor: 7.396
Authors: Lonnie K Zeltzer; Christopher Recklitis; David Buchbinder; Bradley Zebrack; Jacqueline Casillas; Jennie C I Tsao; Qian Lu; Kevin Krull Journal: J Clin Oncol Date: 2009-03-02 Impact factor: 44.544
Authors: Deborah J Bowen; Catherine M Alfano; Bonnie A McGregor; Alan Kuniyuki; Leslie Bernstein; Kathy Meeske; Kathy B Baumgartner; Josala Fetherolf; Bryce B Reeve; Ashley Wilder Smith; Patricia A Ganz; Anne McTiernan; Rachel Ballard Barbash Journal: Breast Cancer Res Treat Date: 2007-01-27 Impact factor: 4.872
Authors: Leslie L Robison; Gregory T Armstrong; John D Boice; Eric J Chow; Stella M Davies; Sarah S Donaldson; Daniel M Green; Sue Hammond; Anna T Meadows; Ann C Mertens; John J Mulvihill; Paul C Nathan; Joseph P Neglia; Roger J Packer; Preetha Rajaraman; Charles A Sklar; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer Journal: J Clin Oncol Date: 2009-04-13 Impact factor: 44.544
Authors: Lonnie K Zeltzer; Qian Lu; Wendy Leisenring; Jennie C I Tsao; Christopher Recklitis; Gregory Armstrong; Ann C Mertens; Leslie L Robison; Kirsten K Ness Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-02 Impact factor: 4.254
Authors: Brad J Zebrack; Michael A Zevon; Norman Turk; Rajaram Nagarajan; John Whitton; Leslie L Robison; Lonnie K Zeltzer Journal: Pediatr Blood Cancer Date: 2007-07 Impact factor: 3.838
Authors: Christopher J Recklitis; Susan K Parsons; Mei-Chiung Shih; Ann Mertens; Leslie L Robison; Lonnie Zeltzer Journal: Psychol Assess Date: 2006-03
Authors: Leslie L Robison; Ann C Mertens; John D Boice; Norman E Breslow; Sarah S Donaldson; Daniel M Green; Frederic P Li; Anna T Meadows; John J Mulvihill; Joseph P Neglia; Mark E Nesbit; Roger J Packer; John D Potter; Charles A Sklar; Malcolm A Smith; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer Journal: Med Pediatr Oncol Date: 2002-04
Authors: Sunita K Patel; Leticia Miranda; Nicole Delgado; Nicolas Barreto; Anne Nolty; Natalie C Kelly; Karla Wilson; Debbie Toomey; Anna Pawlowska Journal: J Pediatr Psychol Date: 2020-09-01
Authors: Satomi Sato; Nan Li; Stephanie B Dixon; Miho Kato; Hui Zhang; Chi Kong Li; Rebecca M Howell; Wendy M Leisenring; Smita Bhatia; Kevin C Oeffinger; Gregory T Armstrong; Yutaka Yasui; Kevin R Krull; Yin Ting Cheung Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-10-04 Impact factor: 4.254
Authors: Nina S Kadan-Lottick; Daniel J Zheng; Mingjuan Wang; Michael W Bishop; Deo Kumar Srivastava; Wilhelmenia L Ross; Rozalyn L Rodwin; Kirsten K Ness; Todd M Gibson; Sheri L Spunt; Mehmet Fatih Okcu; Wendy M Leisenring; Leslie L Robison; Gregory T Armstrong; Kevin R Krull Journal: J Cancer Surviv Date: 2022-01-21 Impact factor: 4.062
Authors: Tegan J Reeves; Taylor J Mathis; Hailey E Bauer; Melissa M Hudson; Leslie L Robison; Zhaoming Wang; Justin N Baker; I-Chan Huang Journal: Front Public Health Date: 2021-10-29
Authors: Ellen van der Plas; T Leigh Spencer Noakes; Darci T Butcher; Rosanna Weksberg; Laura Galin-Corini; Elizabeth A Wanstall; Patrick Te; Laura Hopf; Sharon Guger; Brenda J Spiegler; Johann Hitzler; Russell J Schachar; Shinya Ito; Brian J Nieman Journal: Neuroimage Clin Date: 2020-09-15 Impact factor: 4.881